APA (7th ed.) Citation

Henry, D. H., Costa, L., Goldwasser, F., Hirsh, V., Hungria, V., Prausova, J., . . . Yeh, H. (2011). Randomized, double-blind study of denosumab versus zoledronic acid in the treatment of bone metastases in patients with advanced cancer (excluding breast and prostate cancer) or multiple myeloma. Journal of clinical oncology, 29(9), 1125. https://doi.org/10.1200/JCO.2010.31.3304

Chicago Style (17th ed.) Citation

Henry, David H., et al. "Randomized, Double-blind Study of Denosumab Versus Zoledronic Acid in the Treatment of Bone Metastases in Patients with Advanced Cancer (excluding Breast and Prostate Cancer) or Multiple Myeloma." Journal of Clinical Oncology 29, no. 9 (2011): 1125. https://doi.org/10.1200/JCO.2010.31.3304.

MLA (9th ed.) Citation

Henry, David H., et al. "Randomized, Double-blind Study of Denosumab Versus Zoledronic Acid in the Treatment of Bone Metastases in Patients with Advanced Cancer (excluding Breast and Prostate Cancer) or Multiple Myeloma." Journal of Clinical Oncology, vol. 29, no. 9, 2011, p. 1125, https://doi.org/10.1200/JCO.2010.31.3304.